Article Figures & Data
Tables
- TABLE 1
Medications for the treatment of acute anxiety in hospitalized patients with COVID-19 infection
Medication Dose Route Caution Alprazolam 0.125–0.25 mg,3 times daily By mouth Respiratory depression Lorazepam 0.5–1 mg, 3 times daily By mouth, intramuscular, intravenousa Respiratory depression Gabapentin 100–300 mg, 3 times daily By mouth Renal clearance Hydroxyzine 25–50 mg, 3 times daily By mouth QTc monitoring Olanzapine 2.5–5 mg, 3 times daily By mouth QTc monitoring Quetiapine 25–50 mg, 3 times daily By mouth QTc monitoring Haloperidol 0.5–1 mg, 3 times daily By mouth, intramuscular, intravenousa QTc monitoring ↵a For intravenous dosing, use half of the oral dose.
In this issue
Jump to section
Related Articles
Cited By...
- No citing articles found.